Topographically supported customized ablation for the management of decentered laser in situ keratomileusis.

Purpose: To evaluate the efficacy, predictability, and safety of topographically supported customized ablations (TOSCAs) for decentered ablations following laser in situ keratomileusis (LASIK).

Design: Prospective nonrandomized clinical trial.

Methods: Nine patients (11 eyes) with LASIK-induced decentered ablations underwent TOSCA following flap lifting. Topographically supported customized ablation was performed using a corneal topographer to obtain a customized ablation profile, combined with a flying spot laser.

Results: Mean follow-up was 9.22 +/- 2.82 months (range 6-12 months). No intra- or postoperative complications were observed. Manifest refraction (spherical equivalent) did not change significantly (pre-TOSCA: -0.14 +/- 1.58 diopters [range, -1.75 to +3.00 diopters] to +0.46 +/- 1.02 diopters [range, -1.00 to +1.75 diopters]; P =.76), whereas there was a statistically significant reduction in the refractive astigmatism (pre-TOSCA: -1.55 +/- 0.60 diopters [range, -3.00 to -0.75 diopters] to -0.70 +/- 0.56 diopters [range, -2.00 to -0.25 diopters]; P =.003). Mean uncorrected visual acuity improved significantly (P <.001) from 0.45 +/- 0.16 (range, 0.2-0.7) to 0.76 +/- 0.29 (range, 0.2-1.2) at last follow-up. Mean best-corrected visual acuity improved from 0.74 +/- 0.22 (range, 0.4-1.0) to 0.95 +/- 0.20 (range, 0.6-1.2; P =.002). Eccentricity showed a statistically significant reduction after TOSCA treatment (pre-TOSCA: 1.59 +/- 0.46 mm [range, 0.88-2.23 mm]; post-TOSCA: 0.29 +/- 0.09 mm [range, 0.18-0.44 mm]; P <.001).

Conclusion: In our small sample, enhancement LASIK procedures with TOSCA appear to improve uncorrected and best-corrected visual acuity as well as eccentricity in patients with LASIK-induced decentered ablation.